Login / Signup

Costs and Effects of Implementing Digital Tomosynthesis in a Population-Based Breast Cancer Screening Program: Predictions Using Results from the To-Be Trial in Norway.

Tron Anders MogerÅsne HolenBerit HanestadSolveig Hofvind
Published in: PharmacoEconomics - open (2022)
DBT may be cost effective if implemented in BreastScreen Norway. However, generalizability of results could depend on factors varying between countries, such as recall rates, program sensitivity and specificity, treatment cost and willingness-to-pay levels.
Keyphrases
  • quality improvement
  • study protocol
  • phase iii
  • randomized controlled trial
  • phase ii
  • magnetic resonance imaging
  • combination therapy
  • young adults
  • open label
  • structural basis
  • smoking cessation
  • childhood cancer